Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Sanofi launches BuscoMint capsules for irritable bowel syndrome

Manufacturer Sanofi has launched BuscoMint Peppermint Oil 0.2ml capsules for treating irritable bowel syndrome (IBS).

Released in October, the gastro-resistant capsules provide relief from abdominal discomfort such as bloating or cramps, especially in people suffering from IBS, the manufacturer said.

Each capsule contains 0.2ml of peppermint oil, equivalent to around 67 cups of peppermint tea, as well as hyoscine butylbromide, Sanofi said.

Sanofi has partnered with health app Cara Care, which gives patients techniques for easing their gastrointestinal issues, to mark the launch of BuscoMint.

Sanofi said: “The Cara Care app can help to track symptoms and aid condition understanding. BuscoMint can be used in combination with a healthy lifestyle to treat symptoms.”

One 24-capsule pack of BuscoMint Peppermint Oil 0.2ml retails at £6.99.

To order, contact your wholesaler

Do you sell many relief items for abdominal pain?

Related Content

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD006911

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel